ADVANCED SOLID TUMORS CANCER
Clinical trials for ADVANCED SOLID TUMORS CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED SOLID TUMORS CANCER trials appear
Sign up with your email to follow new studies for ADVANCED SOLID TUMORS CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug ORB-021 enters human testing for Hard-to-Treat cancers
Disease control Recruiting nowThis early-phase study tests whether the investigational drug ORB-021 is safe and tolerable in 36 adults with advanced solid tumors that have not responded to standard treatments. Researchers will also find the best dose for future studies. Participants will be monitored for side…
Matched conditions: ADVANCED SOLID TUMORS CANCER
Phase: PHASE1 • Sponsor: Orionis Biosciences Inc • Aim: Disease control
Last updated Jun 17, 2026 04:27 UTC
-
New hope for hard-to-treat cancers: targeted combo therapy enters trials
Disease control Recruiting nowThis study tests a new drug (GFH375) combined with either cetuximab or chemotherapy in people with advanced solid tumors that have a specific KRAS G12D mutation. The goal is to see if the combination is safe and can shrink tumors. About 126 adults who have not responded to standa…
Matched conditions: ADVANCED SOLID TUMORS CANCER
Phase: PHASE1, PHASE2 • Sponsor: Genfleet Therapeutics (Shanghai) Inc. • Aim: Disease control
Last updated Jun 16, 2026 12:50 UTC
-
New pill shows promise in early trial for Hard-to-Treat cancers
Disease control Recruiting nowThis early-phase study tests a new daily pill, NDI-219216, in people with advanced solid tumors that have not responded to standard treatments. The main goals are to check safety, side effects, and whether the drug can shrink tumors. About 134 participants will take the pill dail…
Matched conditions: ADVANCED SOLID TUMORS CANCER
Phase: PHASE1, PHASE2 • Sponsor: Nimbus Wadjet, Inc. • Aim: Disease control
Last updated Jun 15, 2026 19:08 UTC
-
New drug PQ203 takes on advanced cancers in early human trial
Disease control Recruiting nowThis early-stage trial tests a new drug, PQ203, in about 80 people with advanced solid tumors, including triple-negative breast cancer, who have run out of standard options. The main goals are to check the drug's safety and find the best dose for future studies. Researchers will …
Matched conditions: ADVANCED SOLID TUMORS CANCER
Phase: PHASE1 • Sponsor: ProteinQure Inc. • Aim: Disease control
Last updated Jun 15, 2026 19:02 UTC
-
Live tumor biopsies could unlock secrets of immunotherapy success
Knowledge-focused Recruiting nowThis study collects live tumor tissue from 2,000 people with various cancers to learn how tumors respond to immunotherapy. Participants undergo a biopsy as part of their normal care, and researchers analyze the samples to find clues about treatment response. The goal is to improv…
Matched conditions: ADVANCED SOLID TUMORS CANCER
Sponsor: Elephas • Aim: Knowledge-focused
Last updated Jun 11, 2026 12:11 UTC